Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. - Wikidata - awgldk - TriplyDB

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

http://www.wikidata.org/entity/Q45411408

about

Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B MR Elastography of Liver Disease: State of the Art.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems.Evaluation of the patient with hepatitis B An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers.A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.Comparison of noninvasive models of fibrosis in chronic hepatitis B.Liver stiffness measurement-based scoring system for significant inflammation related to chronic hepatitis B HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections.Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.Evaluation and treatment of the patient coinfected with hepatitis B and HIV.A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model.Assessment of fibrosis in chronic liver diseases.Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.Liver biopsy findings in chronic hepatitis B.Parameters associated with significant liver histological changes in patients with chronic hepatitis B.Noninvasive scoring system for significant inflammation related to chronic hepatitis B.Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters Biomarkers of liver fibrosis.Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy.Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery.Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B.Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis B.A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.Hepatitis virus infection and age-related cataract Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.

P2860

Q26740195-767E5A59-0948-4BCF-AA12-E37CC51BB852 Q28741501-07A601E0-1F36-46CB-A7AC-001B0D7408C8 Q30403258-80C793A0-8620-4A6B-A4EA-43616F25F859 Q30467234-323457CF-F5A8-4E15-B72E-BE40B883CEF3 Q33671532-7F4C2BCF-7474-4593-A28C-BA659BEBE5EA Q33787655-F8B9DD3C-D51A-4688-9B04-3C82783B763F Q33871707-584EDA94-0DE2-4FE2-B9F2-C4323F4B4883 Q33896660-3D679536-44A8-449B-8B15-FAC04136258F Q33968189-1E6CB2A7-4A29-4FAD-9B6E-C6A3E02B950F Q34184642-7812877C-2089-41FF-9AD6-1176ED17CA7A Q34199677-08F041EA-6AA5-49B3-B739-D25B90233368 Q34435273-164882F5-CDAA-4F79-A3D9-BE3A8B40C5E2 Q34998266-CE5579C9-FC0D-4A5A-8063-6876FCB5C709 Q35594244-0837566F-9101-42A0-9E45-A41098EAD5A6 Q35772764-918A6079-3FDC-4382-8826-C664DC87FFFF Q35879457-07239BC9-4046-4B7C-AF9C-55F07D59EB94 Q36151026-28CA7F71-119E-41BE-999E-D5915863A3F4 Q36875021-F8674FA5-10D9-4F9E-849F-99B479E703F3 Q37017919-EF03EDD9-87BD-4DB3-9357-66E1D84024A9 Q37157397-254C896C-E690-45FE-A320-097C3013A3E0 Q37216879-58EE2BC9-69B2-4C97-A607-65624197E70F Q37387494-C67FF944-954D-4645-B055-4BFB87704F64 Q37399469-7E6B99C5-EFBB-4955-84A6-6C771F6CFCA7 Q37404895-8E20B3D4-2293-4A6D-895A-EEE7BC5AFD4C Q37462537-DBFBCF83-A623-43AD-AD90-9CFCE7B3C3B5 Q37590449-E3CD026F-02A8-4D75-8E7D-759757B5AC98 Q37692297-4E30BC71-1BB8-415E-B880-B9DA940D3B26 Q37707436-D64B36FA-620B-4C3A-A192-375203BB0EA8 Q37825547-0F80A194-E324-4FAD-80BC-9A022180A940 Q38915082-58B847B6-1582-428F-B9BC-83E0DC21B150 Q39735958-B1A38B30-CC5F-430B-8EC6-4472AD30A3E1 Q40062007-A791D766-B87A-4793-BB19-40E0577F5052 Q40122998-5AC711B2-2358-4DB0-8AED-0D00B6C9B0C1 Q40355176-9B9E0504-BC5D-4E5C-B28C-151BB3292F36 Q40678115-9364E25F-BAE9-4009-B89F-BF2CC4CB39B0 Q40743810-75FF7EEA-527E-4F98-9B14-7753C300D0F8 Q41416623-F1EC0AB1-0C08-4432-B223-A0E2F88743DD Q42254850-8375B594-864D-49D8-ABFA-8A3CE1523630 Q42375958-7A707CE3-F4F5-4275-AF56-07FACC918023 Q43014834-B289C116-AF4A-46EB-B66E-BEECC3CBE9CD

P2860

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

http://www.wikidata.org/entity/Q45411408

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Noninvasive markers of liver f ...... B-virus related liver disease.

@en

Noninvasive markers of liver f ...... B-virus related liver disease.

@nl

type

label

Noninvasive markers of liver f ...... B-virus related liver disease.

@en

Noninvasive markers of liver f ...... B-virus related liver disease.

@nl

prefLabel

Noninvasive markers of liver f ...... B-virus related liver disease.

@en

Noninvasive markers of liver f ...... B-virus related liver disease.

@nl

P1433

Q45411408-23140296-2380-424D-9D46-8367BABD3B19

P1476

Q45411408-83449BCA-E020-420E-9902-BEAD3BCA4EAB

P2093

Q45411408-0E7DDD50-E033-4F6B-A52D-77830525EAEB

Q45411408-180688EB-C60F-4D35-BF66-B689185E0E09

Q45411408-4F39D2EE-8FD2-4DC7-B271-9A0BC1DE1675

Q45411408-6543DDD6-3752-4670-8934-53CAE3E71FE3

Q45411408-7A1F233A-A569-42A0-993D-064B8F600DA4

Q45411408-82C1F7FC-67C7-4C92-9CB6-A3BA60730BE2

Q45411408-8B946E79-EF8C-4944-87DA-100494902671

Q45411408-A278A07F-384E-4FC6-A144-2AC3F1D9196B

Q45411408-B42653ED-5183-46E2-BBEF-E28F2216F719

Q45411408-E67166BF-6B7D-4F6B-AE24-BD4308A1404E

P304

Q45411408-40952B09-3A09-495B-8E7E-5EF4FB31CE58

P31

Q45411408-7AD371E4-179C-4FF0-B4E8-AB9C8C39C153

P356

Q45411408-8EC5E585-E6A4-41F0-B656-3FBD80085F9C

P407

Q45411408-F66786FF-0558-4247-A1A1-86557A42020E

P433

Q45411408-5ADEF675-757C-4019-9CAF-857C3EAAD8C7

P478

Q45411408-E7B1F2F7-04F6-479D-8126-1D381679490D

P50

Q45411408-0AC4BD1E-88EE-4502-A40A-C9F2235A8D79

Q45411408-B4A62DDE-46CB-466C-B7D3-FF1265963DF9

Q45411408-EB9FBE8D-9D4E-4152-8660-0F1C541CFA6F

Q45411408-F019162D-253B-4710-A9B4-5CC0A3BD557E

P577

Q45411408-89513268-ADD7-4C28-BF8F-A2D7D0B8172E

P5875

Q45411408-BD65C7E7-6847-4974-9E28-BDAEE85ECC33

P698

Q45411408-1F15A220-0D04-4CD2-AF48-4373486ADA3F

P356

J.1572-0241.2006.00788.X

P1433

The American Journal of Gastroenterology

P1476

Noninvasive markers of liver f ...... B-virus related liver disease.

@en

P2093

Abolfazl Najjari

http://www.w3.org/2001/XMLSchema#string

Arezoo Estakhri

http://www.w3.org/2001/XMLSchema#string

Ashraf Mohamadkhani

http://www.w3.org/2001/XMLSchema#string

Atoosa Fazlollahi

http://www.w3.org/2001/XMLSchema#string

Farhad Ghoujeghi

http://www.w3.org/2001/XMLSchema#string

Ghodrat Montazeri

http://www.w3.org/2001/XMLSchema#string

Hossein Nobakht

http://www.w3.org/2001/XMLSchema#string

Jafar Nasiri

http://www.w3.org/2001/XMLSchema#string

Mohammad Hossein Forouzanfar

http://www.w3.org/2001/XMLSchema#string

Negin Nouri

http://www.w3.org/2001/XMLSchema#string

P304

2537-2545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2006.00788.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Seyed Mohammad Tavangar

Mehdi Mohamadnejad

Reza Malekzadeh

P577

2006-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6764782

http://www.w3.org/2001/XMLSchema#string

P698

17029616

http://www.w3.org/2001/XMLSchema#string